The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Antidepressants for depression in physically ill people
Open accessAbstract
BACKGROUND: There is an increased risk of depression in people with a physical illness. Depression is associated with reduced treatment adherence, poor prognosis, increased disability and higher mortality in many physical illnesses. Antidepressants are effective in the treatment of depression in physically healthy populations, but there is less clarity regarding their use in physically ill patients. This review updates Gill's Cochrane review (2000), which found that antidepressants were effective for depression in physical illness. Since Gill there have been a number of larger trials assessing the efficacy of antidepressants in this context. OBJECTIVES: To determine the efficacy of antidepressants in the treatment of depression in patients with a physical illness. SEARCH STRATEGY: Electronic searches of the Cochrane Depression, Anxiety and Neurosis Review Group (CCDAN) trial registers were conducted together with supplementary searches of The Cochrane Central Register of Controlled Trials (CENTRAL) and the standard bibliographic databases, MEDLINE, EMBASE and PsycINFO. Reference lists of included studies were scanned and trials registers were searched to identify additional unpublished data. Last searches were run in December 2009. SELECTION CRITERIA: Randomised controlled trials comparing the efficacy of antidepressants and placebo in the treatment of depression in adults with a physical illness. Depression included diagnoses of Major Depression, Adjustment Disorder and Dysthymia based on standardised criteria. DATA COLLECTION AND ANALYSIS: The primary outcome was efficacy 6-8 weeks after randomisation. Data were also extracted at three additional time-points (4-5 weeks, 9-18 weeks, >18 weeks). Acceptability and tolerability were assessed by comparing the number of drop-outs and adverse events. Odds ratios with 95% confidence intervals were calculated for dichotomous data (response to treatment). Standardised mean differences with 95% CI were calculated for continuous data (mean depression score). Data were pooled using a random effects model. MAIN RESULTS: Fifty-one studies including 3603 participants were included in the review. Forty-four studies including 3372 participants contributed data towards the efficacy analyses. Pooled efficacy data for the primary outcome provided an OR of 2.33, CI 1.80-3.00, p<0.00001 (25 studies, 1674 patients) favouring antidepressants. Antidepressants were also more efficacious than placebo at the other time-points. At 6-8 weeks, fewer patients receiving placebo dropped out compared to patients treated with an antidepressant. Dry mouth and sexual dysfunction were more common in patients treated with an antidepressant. AUTHORS' CONCLUSIONS: This review provides evidence that antidepressants are superior to placebo in treating depression in physical illness. However, it is likely that publication and reporting biases exaggerated the effect sizes obtained. Further research is required to determine the comparative efficacy and acceptability of particular antidepressants in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
The Prevalence of Comorbid Depression in Adults With Diabetes
Anderson, R. J., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1069 · Cited by 3,926
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Sertraline treatment of major depression in patients with acute MI or unstable angina
Glassman, A. H. (2002) · JAMA · doi:10.1001/jama.288.6.701 · Cited by 1,414
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L. H., Cuffe, M. S., Blazing, M. A., Davenport, C., Califf, R. M., Krishnan, R. R., et al. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1849 · Cited by 934
Prevalence of depression in survivors of acute myocardial infarction: Review of the evidence
Thombs, B. D., Bass, E. B., Ford, D. E., Stewart, K. J., Tsilidis, K. K., Patel, U., Fauerbach, J. A., Bush, D. E., & Ziegelstein, R. C. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.00269.x · Cited by 841
Cited by
Management of Depression in Older Adults: A Review
Kok, R. M., & Reynolds, C. F. (2017) · JAMA · doi:10.1001/jama.2017.5706 · Cited by 890
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Meader, N., King, K., Llewellyn, A., Norman, G., Brown, J., Rodgers, M., Moe-Byrne, T., Higgins, J. P., Sowden, A., & Stewart, G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-82 · Cited by 610
Comorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Shirazian, S., Grant, C. D., Aina, O., Mattana, J., Khorassani, F., & Ricardo, A. C. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2016.09.005 · Cited by 325
Berk, M., Köhler‐Forsberg, O., Turner, M., Penninx, B. W. J. H., Wrobel, A., Firth, J., Loughman, A., Reavley, N. J., McGrath, J. J., Momen, N. C., et al. (2023) · World Psychiatry · doi:10.1002/wps.21110 · Cited by 336
Anxiety and depression-Important psychological comorbidities of COPD.
Pumar, M., Gray, C. R., Walsh, J., Yang, I. A., Rolls, T., & Ward, D. L. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.09.28 · Cited by 272
Depression and Cardiovascular Disorders
Whooley, M. A., & Wong, J. M. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185526 · Cited by 241
“In patients with moderate to severe MDD, antidepressant medications are effective at reducing depressive symptoms (Baumeister et al. 2011, Moncrieff et al. 2004, Rayner et al. 2010).”
BackgroundEvidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236
Staging methods for treatment resistant depression. A systematic review
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.020 · Cited by 210
Baumeister, H., Hutter, N., & Bengel, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008381.pub2 · Cited by 188
Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180
“of depression in physically ill people [64].”
Li, M., Kennedy, E. B., Byrne, N., Gérin-Lajoie, C., Katz, M. R., Keshavarz, H., Sellick, S., & Green, E. (2017) · Psycho-Oncology · doi:10.1002/pon.4286 · Cited by 151
Antidepressants for the treatment of depression in people with cancer
Ostuzzi, G., Matcham, F., Dauchy, S., Barbui, C., & Hotopf, M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub3 · Cited by 158
Self-citationBaumeister, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.025 · Cited by 97
Diez-Canseco, F., Toyama, M., Ipince, A., Perez-Leon, S., Cavero, V., Araya, R., & Miranda, J. J. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9208 · Cited by 85
“In addition to this high comorbidity, for people living with a physical disease, depression has been associated with reduced treatment adherence, poorer prognosis, greater disability, and higher mortality [10-12].”
BackgroundPrice, A., Rayner, L., Okon-Rocha, E., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.230862 · Cited by 90
Self-citationMatcham, F., Rayner, L., Hutton, J., Monk, A., Steel, C., & Hotopf, M. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.01.005 · Cited by 85
Self-citationAmbaw, F., Mayston, R., Hanlon, C., & Alem, A. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007653 · Cited by 75
Antidepressants for the treatment of depression in people with cancer
Vita, G., Compri, B., Matcham, F., Barbui, C., & Ostuzzi, G. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011006.pub4 · Cited by 73
Peeters, F. P. M. L., Ruhe, H. G., Wichers, M., Abidi, L., Kaub, K., van der Lande, H. J., Spijker, J., Huibers, M. J. H., & Schene, A. H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.019 · Cited by 72
“Second, the DM-TRD does not include the presence of somatic co-morbidity (Rayner et al., 2010; van Milligen et al., 2012), childhood adversity (Tunnard et al.”
BackgroundPollok, J., van Agteren, J. E., & Carson-Chahhoud, K. V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012346.pub2 · Cited by 59
“A Cochrane Review examining the eHicacy of antidepressants versus placebo in the general population found that both SSRIs and TCAs were beneficial; with TCAs causing more adverse eHects (Arroll 2009).”
BackgroundResultInfluentialRiblet, N., Larson, R., Watts, B. V., & Holtzheimer, P. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.05.010 · Cited by 41
Doherty, A. M., Axe, C. J., & Jones, D. A. (2022) · BJPsych Open · doi:10.1192/bjo.2022.71 · Cited by 37
Depression and anxiety in supportive oncology
Li, M., Boquiren, V., Lo, C., & Rodin, G. (2011) · Supportive Oncology · doi:10.1016/b978-1-4377-1015-1.00052-7 · Cited by 32
Varela-Moreno, E., Carreira Soler, M., Guzmán-Parra, J., Jódar-Sánchez, F., Mayoral-Cleries, F., & Anarte-Ortíz, M. T. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.746217 · Cited by 29
“On the other hand, treatment with antidepressant drugs is shown to be effective, but they differ substantially with respect to short- and long-term side effects (Hackett et al., 2008; Rayner et al., 2010; Moncrieff, 2011; Baumeister, 2012).”
BackgroundJayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., Pollok, R. C. G., & POP‐IBD study group (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16820 · Cited by 27
“27 We found amongst individuals with IBD who were prescribed a single course of antidepressants, 83% had a record for either diagnosis or symptoms of depression or anxiety following treatment.”
Beaussant, Y., Tarbi, E., Nigam, K., Miner, S., Sager, Z., Sanders, J. J., Ljuslin, M., Guérin, B., Thambi, P., Tulsky, J. A., et al. (2024) · Cancer · doi:10.1002/cncr.35024 · Cited by 25
Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients
Capaldi II, V. F., & Wynn (2010) · Psychology Research and Behavior Management · doi:10.2147/prbm.s10035 · Cited by 25
Metadata
- Authors
- Rayner, L., Price, A., Evans, A., Valsraj, K., Higginson, I. J., & Hotopf, M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-03-17
- Volume
- 2010
- Issue
- 4
- Pages
- CD007503-CD007503
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1557078286
- Cited by
- 195
- References
- 26
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.